Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Biswajit Kar , Reynolds M Delgado III Added: 3 years ago
Cardiogenic shock (CGS) results in inadequate end organ perfusion and is associated with high mortality. For patients presenting with CGS following myocardial infarction (MI), reported rates of mortality range between 55% and 80% despite aggressive pharmacological therapy and use of the intra-aortic balloon pump (IABP). Patients with CGS due to ventricular septal defect (VSD) or ventricular… View more

Intervention
Author(s): Biswajit Kar , Reynolds M Delgado III Added: 3 years ago
Cardiogenic shock (CGS) results in inadequate end organ perfusion and is associated with high mortality. For patients presenting with CGS following myocardial infarction (MI), reported rates of mortality range between 55% and 80% despite aggressive pharmacological therapy and use of the intra-aortic balloon pump (IABP). Patients with CGS due to ventricular septal defect (VSD) or ventricular… View more

Imaging & Diagnostics
Author(s): Jorge Silva Enciso , Eric Adler , Barry H Greenberg Added: 3 years ago
Advanced heart failure (AHF) affects approximately 5–10 % of the current 6.6 million people living with heart failure, having a higher incidence in those above 65 years of age.1 The presence of the disease is associated with 50–80 % mortality at 1 year, indicating the need for innovative therapies to manage the burden of this disease. Heart transplantation is the gold standard for AHF, although… View more

Heart Failure
Cardiac Transplant and Ventricular Assist in Heart Failure
Author(s): Michael T Cain , Michael S Firstenberg , Joseph C Cleveland Jr Added: 2 years ago

Heart Failure
Author(s): James N Kirkpatrick , Susan E Wiegers , J Eduardo Rame , et al Added: 3 years ago
There are at least five million patients with heart failure (HF) in the US, 5% of whom are considered end-stage.1 Mechanical circulatory support (MCS) in the form of ventricular assist devices (VADs) is becoming an increasingly important option for these patients. Previously reserved for rescuing patients in the throes of refractory cardiogenic shock, MCS is now a mainstay of end-stage heart… View more

Imaging & Diagnostics
Christian P Schulze
Job title: University Hospital Jena, Jena, Germany
Ventricular Assist Device - ABIOMED, Inc.
Abiomed: Manufacturer of Impella®Percutaneous Ventricular Assist Device Abiomed, founded in 1981, is a global pioneer in healthcare technology, with a mission to recover hearts and save lives. From the World’s first total replacement heart pump to the World’s smallest heart pump, Abiomed has developed a family of ventricular assist devices (VAD), namely the Impella® platform of percutaneous… View more
Author(s): Srinivas Murali Added: 3 years ago
Introduction Nearly five million Americans suffer from heart failure, with 550,000 new cases diagnosed with this disease each year. Heart failure is responsible for 11 million office visits and over 3.5 million hospitalizations per year in the US, with a total bill of US$23 billion spent annually on treatment. About 250,000 people in the US suffer from severe, end-stage heart failure (NYHA Class… View more

Heart Failure
Prof Federico Pappalardo is Director of CardioThoracic and Vascular Anesthesia and Intensive Care at AO SS Antonio e Biagio e Cesare Arrigo in Alessandria and at AOU Maggiore della Carità in Novara, IT. Prof Pappalardo has been Associate Professor at Vita-Salute San Raffaele University, Milan, (2017-2020), where he worked as Director of the Cardiothoracic Intensive Care Unit (2009-2018) and the… View more
ESC 23: Economic Burden of CVD in the EU
Author(s): Christian Sohns , Philipp Sommer Added: 7 months ago
ESC 2023 — We are joined onsite by Prof Christian Sohns and Prof Philipp Sommer (Heart and Diabetes Centre, Bad Oyenhausen, DE) to discuss the findings from the CASTLE-HTx trial (NCT04649801). CASTLE-HTx (Heart and Diabetes Center North-Rhine Westfalia) aimed to determine if atrial fibrillation ablation has beneficial effects on mortality in patients with end-stage heart failure, who are… View more

Heart Failure

Electrophysiology & Arrhythmia